We are live on ! Find out more
IVVD icon

Invivyd

77 hedge funds and large institutions have $34M invested in Invivyd in 2024 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 23 increasing their positions, 20 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

100% more call options, than puts

Call options by funds: $2K | Put options by funds: $1K

15% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 20

4.35% more ownership

Funds ownership: 59.84%64.19% (+4.3%)

1% more funds holding

Funds holding: 7677 (+1)

8% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 12

53% less capital invested

Capital invested by funds: $72.9M → $34M (-$38.9M)

Holders
77
Holders Change
+1
Holders Change %
+1.32%
% of All Funds
1.01%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
13
Increased
23
Reduced
20
Closed
12
Calls
$2K
Puts
$1K
Net Calls
+$1K
Net Calls Change
+$3K
Name Holding Trade Value Shares
Change
Change in
Stake
MC
1
Maverick Capital
Texas
$5.21M
MIG
2
Mithril II GP
Texas
$4.98M +$8.75M +11,241,580 New
DTC
3
Deep Track Capital
Connecticut
$4.74M -$206K -264,334 -2%
MCM
4
M28 Capital Management
Connecticut
$4.1M
Fidelity Investments
5
Fidelity Investments
Massachusetts
$2.56M -$1.2M -1,545,433 -21%
BlackRock
6
BlackRock
New York
$2.1M +$55.9K +71,833 +2%
Vanguard Group
7
Vanguard Group
Pennsylvania
$1.92M -$20.2K -25,906 -0.6%
RG
8
Redmile Group
California
$1.33M -$41.6K -53,460 -2%
6CM
9
683 Capital Management
New York
$1.33M
BCLSI
10
Bain Capital Life Sciences Investors
Massachusetts
$797K
Geode Capital Management
11
Geode Capital Management
Massachusetts
$708K -$19.1K -24,547 -2%
O
12
OrbiMed
New York
$509K -$451K -579,000 -34%
State Street
13
State Street
Massachusetts
$508K +$98.9K +127,129 +12%
Deutsche Bank
14
Deutsche Bank
Germany
$385K +$177K +227,463 +35%
DFO
15
Duquesne Family Office
New York
$253K
Northern Trust
16
Northern Trust
Illinois
$248K -$7.62K -9,785 -2%
Acadian Asset Management
17
Acadian Asset Management
Massachusetts
$222K -$114K -146,728 -22%
GCP
18
GSA Capital Partners
United Kingdom
$205K +$360K +462,438 New
UBS Group
19
UBS Group
Switzerland
$172K +$261K +334,862 +638%
Two Sigma Investments
20
Two Sigma Investments
New York
$163K +$159K +204,188 +125%
TCM
21
Tang Capital Management
California
$146K
Two Sigma Advisers
22
Two Sigma Advisers
New York
$135K +$220K +282,100 +1,276%
BCM
23
Bridgeway Capital Management
Texas
$134K -$5.99K -7,700 -2%
JP Morgan Chase
24
JP Morgan Chase
New York
$114K +$173K +222,375 +644%
Goldman Sachs
25
Goldman Sachs
New York
$111K +$66K +84,776 +51%

IVVD Hedge Fund Activity: Q4 2024 in Review

77 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Invivyd (IVVD) for Q4 2024, worth a combined $34M — down 53% from $72.9M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new IVVD positions and 12 closed out — a net gain of 1 holder — while 23 added to existing stakes and 20 trimmed.

The largest buyer was GSA Capital Partners, opening a new position worth an estimated $360K. The largest seller was Slate Path Capital, exiting entirely with an estimated $3.81M sold.

  • 77 institutional investors held Invivyd (IVVD) as of Q4 2024, up from 76 in Q3 2024.
  • Funds reported $34M of Invivyd stock for Q4 2024, down 53% quarter-over-quarter.
  • 13 funds opened new Invivyd positions in Q4 2024 and 12 closed out, a net change of +1 holder.
  • The largest Invivyd buyer in Q4 2024 was GSA Capital Partners, an estimated $360K added.
  • The largest Invivyd seller in Q4 2024 was Slate Path Capital, an estimated $3.81M sold.

Based on aggregated 13F filings for Q4 2024.